Supernus Pharmaceuticals, Inc.

ROYAL BANK OF CANADA SUPN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

6,987

Value ($000)

346

Weight

0.0%

2019 Q4 - 2025 Q4 (24 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	346	0.0%	6,987	12/31/2025
2025 Q2	8/14/2025	677	0.0%	21,469	6/30/2025
2025 Q1	11/21/2025	382	0.0%	11,669	3/31/2025
2024 Q4	2/14/2025	250	0.0%	6,940	12/31/2024
2024 Q3	11/14/2024	184	0.0%	5,924	9/30/2024
2024 Q2	11/6/2024	145	0.0%	5,461	6/30/2024
2024 Q1	11/5/2024	138	0.0%	4,040	3/31/2024
2023 Q4	2/14/2024	451	0.0%	15,628	12/31/2023
2023 Q3	11/14/2023	208	0.0%	7,494	9/30/2023
2023 Q2	8/14/2023	141	0.0%	4,692	6/30/2023
2023 Q1	5/15/2023	154	0.0%	4,282	3/31/2023
2022 Q4	2/14/2023	325	0.0%	9,103	12/31/2022
2022 Q3	11/14/2022	129	0.0%	3,799	9/30/2022
2022 Q2	8/15/2022	42	0.0%	1,464	6/30/2022
2022 Q1	5/16/2022	133	0.0%	4,127	3/31/2022
2021 Q4	2/14/2022	262	0.0%	9,020	12/31/2021
2021 Q3	11/15/2021	156	0.0%	5,825	9/30/2021
2021 Q2	8/16/2021	138	0.0%	4,491	6/30/2021
2021 Q1	7/20/2021	69	0.0%	2,658	3/31/2021
2020 Q4	2/16/2021	522	0.0%	20,755	12/31/2020
2020 Q3	11/16/2020	429	0.0%	20,596	9/30/2020
2020 Q2	8/14/2020	496	0.0%	20,873	6/30/2020
2020 Q1	6/16/2020	381	0.0%	21,181	3/31/2020
2019 Q4	2/14/2020	44	0.0%	1,884	12/31/2019